Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva Pharmaceuticals USA Inc.

Division of Teva Pharmaceutical Industries Ltd.
www.tevausa.com

Latest From Teva Pharmaceuticals USA Inc.

Sanders Maintains The Pressure On Teva, Mylan and Heritage

After urging the US DoJ to act against pharma companies alleged to have conspired in a price-fixing conspiracy, Bernie Sanders and Elijah Cummings write letters to Teva, Mylan and Heritage, accusing the companies of obstructing their enquiry.

Pricing Debate Pricing Strategies

Teva Gives Up Its Store-Brand OTC Portfolio To PLD

Teva’s US store-brand OTC portfolio including 40 approved and pending ANDA offerings has been acquired by the family-owned PL Developments.  
OTC Drugs Deals

GDUFA III May Rely Less On PDUFA As A Role Model

Meeting opportunities codified in GDUFA II were adapted from the new drug user fee program experience but may not be well suited to the commodified generic drug industry built on volume and speed, industry representatives said at the recent FDLI annual meeting.

Generic Drugs Drug Approval Standards

Heritage Is First To Settle DOJ Generic Drug Price Fixing Probe

Heritage agrees to pay $7.1m to resolve civil allegations and a $225,000 criminal penalty. DOJ defers prosecution of one felony charge.

Legal Issues Generic Drugs
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Cancer
  • Gynecological, Urological
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Teva Pharmaceuticals USA
  • Biocraft Laboratories Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Teva Pharmaceutical Industries Ltd.
  • Senior Management
  • Contact Info
  • Teva Pharmaceuticals USA Inc.
    Phone: (888) 838-2872
    1090 Horsham Rd.
    N. Wales, PA 19454
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register